These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28600817)

  • 1. Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation.
    Charruyer A; Fong S; Vitcov GG; Sklar S; Tabernik L; Taneja M; Caputo M; Soeung C; Yue L; Uchida Y; Arron ST; Horton KM; Foster RD; Sano S; North JP; Ghadially R
    Stem Cells; 2017 Aug; 35(8):2001-2007. PubMed ID: 28600817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
    Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
    Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesions.
    Jia HY; Shi Y; Luo LF; Jiang G; Zhou Q; Xu SZ; Lei TC
    Int J Mol Med; 2016 Feb; 37(2):359-68. PubMed ID: 26707630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes.
    Chen B; Li C; Chang G; Wang H
    Bioengineered; 2022 Jan; 13(1):1530-1540. PubMed ID: 35006038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased p53 is associated with a decline in asymmetric stem cell self-renewal in aged human epidermis.
    Charruyer A; Weisenberger T; Li H; Khalifa A; Schroeder AW; Belzer A; Ghadially R
    Aging Cell; 2021 Feb; 20(2):e13310. PubMed ID: 33524216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression.
    Tang L; Zhang B; Li G; Zhu Y; Feng B; Su Z; Han W; Huang H; Li Q; Wang M; Chen Y; Liu H; Dai Z; Wu D; Li H; Yang L; Lu Y; Ye Z; Zheng G
    J Nat Med; 2023 Sep; 77(4):712-720. PubMed ID: 37306932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
    Takahashi T; Koga Y; Kainoh M
    Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
    Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
    Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development.
    Zhang W; Guo S; Li B; Liu L; Ge R; Cao T; Wang H; Gao T; Wang G; Li C
    J Pathol; 2017 Feb; 241(3):392-404. PubMed ID: 27859256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
    J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.
    Al-Harbi NO; Nadeem A; Al-Harbi MM; Zoheir KMA; Ansari MA; El-Sherbeeny AM; Alanazi KM; Alotaibi MR; Ahmad SF
    Immunobiology; 2017 Feb; 222(2):128-136. PubMed ID: 27773660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.
    Ippagunta SK; Gangwar R; Finkelstein D; Vogel P; Pelletier S; Gingras S; Redecke V; Häcker H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6162-E6171. PubMed ID: 27671649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17.
    Yang L; Fan X; Cui T; Dang E; Wang G
    J Invest Dermatol; 2017 Oct; 137(10):2168-2176. PubMed ID: 28576737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
    Nadeem A; Ahmad SF; Al-Harbi NO; Fardan AS; El-Sherbeeny AM; Ibrahim KE; Attia SM
    Cytokine; 2017 Sep; 97():14-24. PubMed ID: 28570931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.
    Meephansan J; Komine M; Tsuda H; Karakawa M; Tominaga S; Ohtsuki M
    J Dermatol Sci; 2013 Aug; 71(2):107-14. PubMed ID: 23764374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.